Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 May 2024 | Story Anthony Mthembu | Photo Jon Vincent
Ibali
Educators, academics, and policymakers in attendance at the Ibali Education Stakeholders Forum.

The Centre for Development Support (CDS) at the University of the Free State (UFS), in collaboration with Ibali, hosted the Ibali Education Stakeholders Forum on 10 May 2024 at the Centenary Complex on the UFS Bloemfontein Campus. 

According to Prof Faith Mkwananzi, Associate Professor at the CDS, the event, an initiative of the Ibali Project, aimed to ‘’inform and disseminate project findings to individuals with an interest in educational exclusion and inclusion. It also served as a forum for stakeholders to share insights on the matter. “ The forum was well attended by educators, school leaders, academics, and policymakers from the Free State. Additionally, the event saw representation from Ibali, including Dr Alison Buckler, Deputy Director of the Centre for the Study of Global Development (CSGD) at The Open University.

A platform for engagement

Discussions at the forum focused on creating inclusive learning environments for learners and students within the province and beyond. Stakeholders had the opportunity to discuss the challenges they face in fostering inclusive learning spaces through panel discussions and presentations. ’’The involvement of stakeholders and presentation of diverse perspectives contributed to a robust engagement, indicating that individuals and organisations are motivated to support an inclusive and sustainable education system at every level in South Africa,’’ said Prof Mkwananzi.

The Ibali initiative

Dr Buckler explained that Ibali is a network of researchers, practitioners, and educators interested in how storytelling can support different understandings around complex issues in education and development. One of Ibali’s projects, funded by the United Kingdom Arts and Humanities Research Council (AHRC), explores what inclusion and exclusion look like within education in countries like Nigeria, South Africa, and the United Kingdom.

Insights from the engagement

Dr Buckler highlighted several insights from the forum. She noted that inclusive practice can manifest in various ways. ‘’People talked about mixing groups of students in lectures, creating a supportive community for their deaf sibling, mainstream schools inviting children from ‘special schools’ for play sessions, and so on,’’ she said. Moreover, she emphasised that a key takeaway is that “underpinning hugely diverse examples of inclusive practice are a fairly small number of key principles around empathy, communication, ubuntu, and seeing someone as whole instead of defining people by certain characteristics that align with inclusion policies.”

As the engagement session concluded, both Prof Mkwananzi and Dr Buckler expressed hope that stakeholders could learn from one another’s experiences, fostering a more inclusive educational environment.  

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept